BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khare T, Palakurthi SS, Shah BM, Palakurthi S, Khare S. Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E3956. [PMID: 32486445 DOI: 10.3390/ijms21113956] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Nuthakki VK, Choudhary S, Reddy CN, Bhatt S, Jamwal A, Jotshi A, Raghuvanshi R, Sharma A, Thakur S, Jadhav HR, Bharate SS, Nandi U, Kumar A, Bharate SB. Design, Synthesis, and Pharmacological Evaluation of Embelin-Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood-Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer's Disease: Discovery of SB-1448. ACS Chem Neurosci 2023;14:1193-219. [PMID: 36812360 DOI: 10.1021/acschemneuro.3c00030] [Reference Citation Analysis]
2 Ninsiima HI, Eze ED, Ssekatawa K, Nalugo H, Asekenye C, Onanyang D, Munanura EI, Ariong M, Matama K, Zirintunda G, Mbiydzenyuy NE, Ssempijja F, Afodun AM, Mujinya R, Usman IM, Asiimwe OH, Tibyangye J, Kasozi KI. Green tea silver nanoparticles improve physiological motor and cognitive function in BALB/c mice during inflammation. Heliyon 2023;9:e13922. [PMID: 36873543 DOI: 10.1016/j.heliyon.2023.e13922] [Reference Citation Analysis]
3 Bao M, Wang K, Li J, Li Y, Zhu H, Lu M, Zhang Y, Fan Q, Han L, Wang K, Wang D, Gao Y, Peng B, Ming Z, Liu W. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease. Acta Biomater 2023:S1742-7061(23)00107-1. [PMID: 36863680 DOI: 10.1016/j.actbio.2023.02.026] [Reference Citation Analysis]
4 Zhou Y, Wang D, Yan W. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments. Nutrients 2023;15. [PMID: 36839389 DOI: 10.3390/nu15041031] [Reference Citation Analysis]
5 Monteiro P, Cotas J, Lomartire S, Rocha CP, Pereira L, Mendes Gonçalves AM. Advanced instruments in algae materials. Algae Materials 2023. [DOI: 10.1016/b978-0-443-18816-9.00002-2] [Reference Citation Analysis]
6 Luo Y, De Souza C, Ramachandran M, Wang S, Yi H, Ma Z, Zhang L, Lin K. Precise oral delivery systems for probiotics: A review. J Control Release 2022;352:371-84. [PMID: 36309096 DOI: 10.1016/j.jconrel.2022.10.030] [Reference Citation Analysis]
7 Bitari A, Oualdi I, Touzani R, Elachouri M, Legssyer A. Zingiber officinale Roscoe: A comprehensive review of clinical properties. Materials Today: Proceedings 2022. [DOI: 10.1016/j.matpr.2022.09.316] [Reference Citation Analysis]
8 Gowd V, Kanika, Jori C, Chaudhary AA, Rudayni HA, Rashid S, Khan R. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease. J Nutr Biochem 2022;109:109101. [PMID: 35777588 DOI: 10.1016/j.jnutbio.2022.109101] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Rahiman N, Markina YV, Kesharwani P, Johnston TP, Sahebkar A. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases. J Control Release 2022;348:264-86. [PMID: 35649486 DOI: 10.1016/j.jconrel.2022.05.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Talebi M, Talebi M, Farkhondeh T, Samarghandian S. Therapeutic Effects of Resveratrol in Inflammatory Bowel Diseases: Shedding Light on the Role of Cellular and Molecular Pathways. Rev Bras Farmacogn 2022;32:160-173. [DOI: 10.1007/s43450-022-00247-9] [Reference Citation Analysis]
11 Melim C, Magalhães M, Santos AC, Campos EJ, Cabral C. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. Expert Opin Drug Deliv 2022. [PMID: 35166619 DOI: 10.1080/17425247.2022.2041599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hamid R, Manzoor I. Nanomedicines: Nano based Drug Delivery Systems Challenges and Opportunities. Alternative Medicine - Update 2021. [DOI: 10.5772/intechopen.94353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Quispe C, Cruz-Martins N, Manca ML, Manconi M, Sytar O, Hudz N, Shanaida M, Kumar M, Taheri Y, Martorell M, Sharifi-Rad J, Pintus G, Cho WC. Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases. Oxid Med Cell Longev 2021;2021:3149223. [PMID: 34584616 DOI: 10.1155/2021/3149223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
15 Fan W, Zhang S, Wu Y, Lu T, Liu J, Cao X, Liu S, Yan L, Shi X, Liu G, Huang C, Song S. Genistein-Derived ROS-Responsive Nanoparticles Relieve Colitis by Regulating Mucosal Homeostasis. ACS Appl Mater Interfaces 2021;13:40249-66. [PMID: 34424682 DOI: 10.1021/acsami.1c09215] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
16 Lima IB, Moreno LC, Silva-filho EC, Irache JM, Veiga FJ, Rolim HM, Nunes LC. Development of nanostructured systems using natural polymers to optimize the treatment of inflammatory bowel diseases: A prospective study. Journal of Drug Delivery Science and Technology 2021;64:102590. [DOI: 10.1016/j.jddst.2021.102590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Basha NJ, Basavarajaiah SM, Baskaran S, Kumar P. A comprehensive insight on the biological potential of embelin and its derivatives. Nat Prod Res 2021;:1-15. [PMID: 34304655 DOI: 10.1080/14786419.2021.1955361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
19 Barani M, Rahdar A, Sargazi S, Amiri MS, Sharma PK, Bhalla N. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and Bio-Sensing Research 2021;32:100417. [DOI: 10.1016/j.sbsr.2021.100417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
20 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
21 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
22 Placha D, Jampilek J. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 2021;13:64. [PMID: 33419176 DOI: 10.3390/pharmaceutics13010064] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
23 Lama S, Merlin-Zhang O, Yang C. In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines. Nanomaterials (Basel) 2020;10:E2177. [PMID: 33142878 DOI: 10.3390/nano10112177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Shah BM, Palakurthi SS, Khare T, Khare S, Palakurthi S. Natural proteins and polysaccharides in the development of micro/nano delivery systems for the treatment of inflammatory bowel disease. Int J Biol Macromol 2020;165:722-37. [PMID: 33010274 DOI: 10.1016/j.ijbiomac.2020.09.214] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]